Nalaganje...
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
Fatigue is a common and debilitating symptom in patients with RA. Since 2007, fatigue has been included as one of the core outcome measures in RA. Clinical trials of biologic DMARDs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) have included fatigue as a secondary endpoint. A Cochrane review in...
Shranjeno v:
| izdano v: | Rheumatology (Oxford) |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827260/ https://ncbi.nlm.nih.gov/pubmed/31682274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez389 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|